HKLife battles to develop diagnostic tests for COVID-19
海康为COVID-19开发诊断测试而战
Both teams of HKLife, in Hong Kong and in Beijing, are working around the clock to develop sensitive and specific diagnostic tests for the new coronavirus COVID-19. Due to the epidemic crisis, the government rapidly put in place compulsory control measures for municipal transportation and postponed resumption to work. This meant that for outsourced experimental reagents, such as enzymes, primers, and reagents, either the items were out of stock or staff members still had not resumed work. Moreover, we could not gain access to viral samples to act as positive controls. All these external factors hindered our progress but our team undertook positive counter measures: where delivery was delayed, we went to pick up in person; where one supplier was out of stock, we contacted ten other suppliers; where necessary, we prepared the reagents ourselves; and we used synthesized plasmids for positive control. We overcame all these difficulties, and each member of the team continues to maintain an enthusiastic and fighting spirit. The test results are very promising and development of the diagnostic tests look close to success. We hope that our diagnosis platforms can help to resolve the urgent need for accurate diagnostics and contribute to the fight against the epidemic.
海康的精英团队(分别在香港和北京)全天候工作，为新的冠状病毒COVID-19开发高灵敏度及特异性稳定的诊断产品。因正值疫情特别时期，国家对市政交通、市民延期复工有强制管控措施，所以我们外购的实验原材料，例如试剂组分所需的酶、引物、阳性对照供应商缺货，且多数企业员工还未复工，实验测试所必须的病毒样品我们无法获得，种种外界因素给实验带来重重阻碍。团队积极采取应对措施，延期发货的，我们亲自提货，一家延期，我们再找寻10家，选择最快的；缺少病毒样品作阳性对照，我们使用合成的质粒作为替代。我们克服了一切困难，团队每位成员保持激昂的热情和斗志，犹如战士冲锋陷阵，攻无不克、战无不胜，历时一周多的时间，验证测试结果令人非常满意，我们用事实数据说话，诊断测试产品即将面世。希望多诊断平台的产品可以帮助卫生系统解决对准确诊断的迫切需求，并为抗击疫情做出自己的贡献。
WE ARE CLOSE. KEEP ON FIGHTING!
我们快成功了! 加油!
 Hong Kong team 香港团队Left to right: Kaka KAR, Iris HO, Queenie FONG, Dr. Zhaoyang YE, Dr. Timothy HO, Dr. Jodie XU从左至右：賈寶怡、何婉芳、方文君、叶朝阳 博士、何耀昌 博士、徐舟 博士 |  Beijing team 北京团队Left to right: Xiaotian LI、Hexin FEI、Nannan ZHAO、Jing HAN、Yingxiao LIAN、Fumeng LI、Dr. Huajian ZHAO、Qianqian AI、Yi YUE、June WANG、Dr. Xiaowei SHI、Yufen GUO 从左至右：李晓天、费鹤馨、赵楠楠、韩晶、廉迎晓、李付梦、赵化建 博士、艾倩倩、岳艺、王双艳、史小伟 博士、郭玉芬 |
Professor Albert Cheung-hoi YU, Chairman of Hai Kang Life Corporation Limited, attended the 2018 Board Meeting of Gordon Research Conference (Honolulu, Hawaii). Professor Yu is the only Chinese member of the board.
English 
Chinese